← All indications
Arsenic Poisoning
Disorders associated with acute or chronic exposure to compounds containing ARSENIC (ARSENICALS) which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse (Mees) lines in the fingernails. (Adams et al., Principles of Neurology, 6th ed, p1212)
Drugs by status
Approved for this indication (1)
Phase 3 trials (1)
Phase 2 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Other Experimental Indications (1)